Allen & Overy Reps Novartis In $5B 3-Part Bond Issue

Law360, New York (March 10, 2010, 5:30 PM EST) -- Swiss pharmaceutical giant Novartis AG has revealed plans to launch a $5 billion bond market transaction in three increments, saying the proceeds would be primarily funneled toward its pending $28.1 billion acquisition of eye care company Alcon Inc.

The transaction will be issued in three parts, the company said Tuesday: $2 billion in 1.9 percent notes due April 24, 2013; $2 billion in 2.9 percent notes due April 24, 2015; and $1 billion in 4.4 percent notes due April 24, 2020.

Proceeds from the offering will...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.